Copyright 2019 Hubbard Radio Washington DC, LLC. All rights reserved. This website is not intended for users located within the European Economic Area.
SILVER SPRING, Md. (AP) _ United Therapeutics Corp. (UTHR) on Wednesday reported second-quarter net income of $205.1 million.
The Silver Spring, Maryland-based company said it had net income of $4.66 per share. Earnings, adjusted for stock option gains and non-recurring gains, were $3.63 per share.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $2.40 per share.
The drugmaker posted revenue of $373.6 million in the period, also surpassing Street forecasts. Five analysts surveyed by Zacks expected $331.8 million.
United Therapeutics shares have decreased 27% since the beginning of the year. The stock has fallen 34% in the last 12 months.
Copy: Insight by Akamai: Get the latest information on defense networks and cloud strategy with the exclusive Federal News Network DoD Strategic IT Survey.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on UTHR at https://www.zacks.com/ap/UTHR
Copyright © 2019 The Associated Press. All rights reserved. This website is not intended for users located within the European Economic Area.